Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|2|3|249-258

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.2, Iss.3, 2004-07, pp. : 249-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Variant in the Endothelin-Converting Enzyme-Like 1 (ECEL1) Gene in an Emirati Child

By  

Medical Principles and Practice, Vol. 26, Iss. 2, 2017-01 ,pp. : 195-198

Karger

Access to resources Recommend Favorite

Endothelin-1 and Human Platelets

By  

Current Vascular Pharmacology, Vol. 3, Iss. 4, 2005-10 ,pp. : 393-399

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelin-1 Actions on Vascular Smooth Muscle Cell Functions As a Target for the Prevention of Atherosclerosis

By  

Current Vascular Pharmacology, Vol. 6, Iss. 3, 2008-07 ,pp. : 195-203

Bentham Science Publishers

Access to resources Recommend Favorite

The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies

By  

Current Vascular Pharmacology, Vol. 5, Iss. 3, 2007-07 ,pp. : 239-248

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelin-1 and the Aortic Valve

By  

Current Vascular Pharmacology, Vol. 3, Iss. 4, 2005-10 ,pp. : 353-357

Bentham Science Publishers

Access to resources Recommend Favorite